Protandim

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameProtandim

Drug Alias Namederived from five different plants: Silybum marianum (milk thistle), Withania somnifera (Ashwagandha), Camellia sinensis (green tea), Curcuma longa (turmeric) and Bacopa monniera

ClassificationNatural product/Extract > Plants extract

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeuroinflammatory DiseasesSchizophreniaAmyotrophic Lateral Sclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIndonesia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesTemple University Duke University

China Registration ClassN/A

Develop Information

Active CompaniesDuke University Temple University Hasanuddin University

Inactive CompaniesN/A

Active IndicationsNeuroinflammatory DiseasesSchizophreniaAmyotrophic Lateral Sclerosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A